Altered mRNA expression of ecNOS and iNOS in myometrium and placenta from women with preeclampsia

被引：29

作者：

Faxén M. ^{[1
]}

Nisell H. ^{[1
]}

Kublickiene K.-R. ^{[1
]}

机构：

[1] Center for Genomics Research, (CGR) Karolinska Institute

来源：

Archives of Gynecology and Obstetrics | 2001年 / 265卷 / 1期

关键词：

mRNA expression; Myometrium; Nitric oxide synthases; Placenta; Preeclampsia;

D O I：

10.1007/s004040000152

中图分类号：

学科分类号：

摘要：

Objective: Preeclampsia is a syndrome involving dysfunction of vascular endothelium and imbalance between endothelium derived constricting and relaxing factors. Recent evidence suggests that endothelium-derived nitric oxide (NO) plays a role in the regulation of vascular resistance during normal pregnancy and preeclampsia. NO is a potent vasodilator and is generated by the catalytic action of nitric oxide synthases ecNOS and iNOS in myometrium and placenta. Methods: In this study mRNA expressions of ecNOS and iNOS were compared in myometrium and placenta. Biopsies were collected from women with preeclampsia (n=8) and normal pregnancies (n=12). ecNOS and iNOS mRNA levels were determined using RT-PCR and expressed as arbitrary units after correction for control GAPDH gene mRNA levels. Results: The mRNA expression of ecNOS was significantly higher in both myometrium (p<0.05) and placenta (p<0.05) from women with preeclampsia compared to that in normal pregnancies, while the iNOS mRNA level was not altered in myometrium and lower in placenta (p<0.05) from women with preeclampsia. Conclusions: The higher ecNOS mRNA expression might be a compensatory response to an impaired vasodilatation in the uteroplacental circulation during preeclampsia. Whether the similar and reduced levels of iNOS mRNA expression in myometrium and placenta, respectively, in women with preeclampsia is of importance remains to be further evaluated.

引用

页码：45 / 50

页数：5

共 41 条

[1]

Allen J., Forman A., Maigaard S., Jespersen L.T., Andersson K.E., Effects of endogenous vasoconstrictors on maternal intramyometrial and fetal stem villous arteries in pre-eclampsia, J Hypertens, 7, pp. 529-536, (1989)

[2]

Ashworth J.R., Baker P.N., Warren A.Y., Warren A.Y., Phil M., Johnson I.R., Mechanisms of endothelium-dependent relaxation in myometrial resistance vessels and their alteration in preeclampsia, Hypertens Preg, 18, pp. 57-71, (1999)

[3]

Baker P.N., Davidge S.T., Roberts J.M., Plasma from women with preeclampsia increases endothelial cell nitric oxide production, Hypertension, 26, pp. 244-248, (1995)

[4]

Bansal R.K., Goldsmith P.C., He Y., Zaloudek C.J., Ecker J.L., Riemer R.K., A decline in myometrial nitric oxide synthase expression is associated with labor and delivery, J Clin Invest, 99, pp. 2502-2508, (1997)

[5]

Bhagat K., Vallance P., Effects of cytokines on nitric oxide pathways in human vasculature, Curr Opin Nephrol Hypertens, 8, pp. 89-96, (1999)

[6]

Brown M.A., The physiology of pre-eclampsia, Clin Exp Pharmacol Physiol, 20, pp. 781-791, (1995)

[7]

Cameron I.T., Van Paperndorp C.L., Palmer R.M.J., Smith S.K., Moncada S., Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy, Hypertens Preg, 12, pp. 85-92, (1993)

[8]

Chomczynski P., Sacchi N., Single-step method of RNA isolation by acid guandinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, pp. 156-159, (1987)

[9]

Chu S.C., Marks-Konczalik J., Wu H.P., Banks T.C., Moss J., Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: Characterization of differences between human and mouse iNOS promoter, Biochem Biophys Res Commun, 248, pp. 871-878, (1998)

[10]

Davidge S.T., Baker P.N., Roberts J.M., OS expression is increased in endothelial cells exposed to plasma from women with preeclampsia, Am J Physiol, 269, (1995)

← 1 2 3 4 5 →